This evidence-informed consensus guideline was developed to address the safe handling of oral anti-cancer drugs (OACDs) in community pharmacies across the medication lifecycle, from manufacturer packaging to waste management and incident reporting.
The primary target audience is community pharmacy staff, from the most senior decision makers who have the authority to influence organization wide policy and practice, to front line pharmacists and pharmacy assistants/technicians.
However, because the recommendations will also be relevant to manufacturers, distributors, and third parties involved in packaging, distribution, or removal of OACDs to or from community pharmacies, there are many other groups and individuals for whom this document will be relevant.
